Effect of farnesyltransferase inhibitors on SARS-CoV-2

OBJECTIVES: The emergence of SARS-CoV-2 in 2019 led to a severe pandemic situation. Treatment options are limited, and the efficacy of vaccines decreases due to mutations in SARS-CoV-2 strains. Therefore, new treatment options are urgently needed, and computational compound screenings are used to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Lea, Mautner, Lena, Hoyos, Mona, Ehrhardt, Anja, Baiker, Armin, Bachmann, Hagen Sjard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2023
Materias:
SARS CoV-2 Dispatches
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711904/
https://www.ncbi.nlm.nih.gov/pubmed/36462736
http://dx.doi.org/10.1016/j.jgar.2022.11.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711904/
https://www.ncbi.nlm.nih.gov/pubmed/36462736
http://dx.doi.org/10.1016/j.jgar.2022.11.011

Ejemplares similares